Relay Therapeutics Inc (RLAY)’s financial ratios: A comprehensive overview

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.17 million shares were traded. RLAY stock price reached its highest trading level at $6.7499 during the session, while it also had its lowest trading level at $6.365.


We take a closer look at RLAY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 20.73 and its Current Ratio is at 20.73. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

On April 20, 2023, Jefferies Upgraded its rating to Hold which previously was Underperform but kept the price unchanged to $12.50.

Raymond James Upgraded its Outperform to Strong Buy on April 19, 2023, while the target price for the stock was maintained at $29.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 29 ’24 when Bergstrom Donald A sold 2,686 shares for $6.38 per share. The transaction valued at 17,137 led to the insider holds 527,427 shares of the business.

Catinazzo Thomas sold 1,695 shares of RLAY for $10,814 on Apr 29 ’24. The Chief Financial Officer now owns 339,803 shares after completing the transaction at $6.38 per share. On Apr 29 ’24, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,623 shares for $6.38 each. As a result, the insider received 10,355 and left with 325,767 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 852203648 and an Enterprise Value of 154899568. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.12 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 4.385 whereas that against EBITDA is -0.426.

Stock Price History:

The Beta on a monthly basis for RLAY is 1.67, which has changed by -0.35735738 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $13.32, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -14.93%, while the 200-Day Moving Average is calculated to be -28.57%.

Shares Statistics:

According to the various share statistics, RLAY traded on average about 1.24M shares per day over the past 3-months and 1081850 shares per day over the past 10 days. A total of 127.46M shares are outstanding, with a floating share count of 93.31M. Insiders hold about 29.70% of the company’s shares, while institutions hold 70.58% stake in the company. Shares short for RLAY as of 1714435200 were 11525155 with a Short Ratio of 9.30, compared to 1711584000 on 11172603. Therefore, it implies a Short% of Shares Outstanding of 11525155 and a Short% of Float of 11.1499995.

Most Popular

[the_ad id="945"]